Live Breaking News & Updates on Outpatient Treatment With

(1)
DJ EQS-News: Antengene Announces XPO1 Inhibitor Selinexor Prescribed for the First Time in the Pilot Zone of Hainan Province and Authorized to be Expanded Beyond the Pilot Zone for Outpatient Treatment EQS-News / 29/04/2021 / 11:36 UTC+8 Antengene Announces XPO1 Inhibitor Selinexor Prescribed for the First Time in the Pilot Zone of Hainan Province and Authorized to be Expanded Beyond the Pilot Zone for Outpatient Treatment With the official release and implementation of the Overall Plan for the Construction of Hainan Free Trade Port, patient can now access global innovative medicines in mainland China. Recently, the global first-in-class selective inhibitor of nuclear export (SINE) compound, selinexor (XPOVIO(R)), was prescribed for the first time in mainland China at the Boao Super Hospital in Boao Lecheng Pilot Zone and has been authorized to be expanded beyond the Pilot Zone for the outpatient treatment of relapsed or refractory multiple myeloma (rrMM). Prescribing s ....

Hainan Province , Hong Kong , Boao Lecheng , Hongxia Yao , Asia Pacific , National Comprehensive Cancer Network Nccnr Guidelines , Hematological Lymphoma Department Of Hainan Cancer Hospital , Antengene Corporation Limited , People Daily , Karyopharm Therapeutics Inc , Boao Lecheng International Medical Tourism Pilot Zone , Financial Press , Patient Program , Name Patient Program , Hainan Chengmei Medicine Co Ltd , National Comprehensive Cancer Network , Antengene Announces , Selinexor Prescribed , First Time , Pilot Zone , Expanded Beyond , Outpatient Treatment , Outpatient Treatment With , Overall Plan , Hainan Free Trade Port , Boao Super Hospital ,